Literature DB >> 23528024

Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder.

Tobias Pagel1, Ross J Baldessarini, Jeremy Franklin, Christopher Baethge.   

Abstract

OBJECTIVES: Information on basic demographic and clinical characteristics of schizoaffective disorder is sparse and subject to sampling bias and low diagnostic reliability. In the present study we aimed to: (i) estimate the demographic and clinical descriptors in schizoaffective disorder patients and (ii) compare the findings with those with schizophrenia and bipolar disorder.
METHODS: To minimize sampling bias and low reliability, we systematically reviewed studies that simultaneously compared schizoaffective, schizophrenia, and bipolar disorder patients. We estimated demographic, clinical, and psychometric characteristics based on weighted pooling, and compared disorders by meta-analysis. We also estimated whether schizoaffective disorder is closer to schizophrenia or to bipolar disorder.
RESULTS: We identified 50 studies that included 18312 patients. Most characteristics of the 2684 schizoaffective disorder patients fell between those of 4814 diagnosed with bipolar disorder and 10814 with schizophrenia. However, the schizoaffective group had the highest proportion of women (52%), had the youngest age at illness onset (23.3 ± 3.8 years), and had the highest standardized ratings of psychosis and depression. Differences in pooled parameters between schizoaffective versus schizophrenia and versus bipolar disorder subjects were similar. Values for patients with schizoaffective disorders mostly were intermediate between schizophrenia and bipolar disorder. However, the majority of studies showed schizoaffective patients to be more like schizophrenia than bipolar disorder patients in seven out of nine demographic and clinical categories as well as in five out of eight psychometric measures. These results remained similar when we restricted the analyses to studies with psychotic bipolar disorder patients only or to studies using the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IIIR and DSM-IV only.
CONCLUSIONS: The present study provided estimates of important characteristics of schizoaffective disorder - as balanced as possible in summarizing the findings from observational studies as unbiased as possible. The results did not support the hypothesis that schizoaffective disorder is primarily an affective disorder. The stronger resemblance of schizoaffective disorder to schizophrenia than to bipolar disorder needs further investigation.
© 2013 John Wiley and Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23528024     DOI: 10.1111/bdi.12057

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  17 in total

1.  Characteristics and Service Use of Older Adults with Schizoaffective Disorder Versus Older Adults with Schizophrenia and Bipolar Disorder.

Authors:  Stephanie A Rolin; Kelly A Aschbrenner; Karen L Whiteman; Emily Scherer; Stephen J Bartels
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-03       Impact factor: 4.105

2.  Nicotine dependence and psychosis in Bipolar disorder and Schizoaffective disorder, Bipolar type.

Authors:  Elena Estrada; Sarah M Hartz; Jeffrey Tran; Donald M Hilty; Pamela Sklar; Jordan W Smoller; Michele T Pato; Carlos N Pato
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-10-15       Impact factor: 3.568

3.  Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Tara Kingston; Paul J Scully; David J Browne; Patrizia A Baldwin; Anthony Kinsella; Eadbhard O'Callaghan; Vincent Russell; John L Waddington
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

4.  Relationship between neuropsychological behavior and brain white matter in first-episode psychosis.

Authors:  Andreia V Faria; Jeffrey Crawford; Chenfei Ye; Johnny Hsu; Anshel Kenkare; David Schretlen; Akira Sawa
Journal:  Schizophr Res       Date:  2019-04-13       Impact factor: 4.939

5.  Psychopathological and demographic characteristics of hallucinating patients with schizophrenia and schizoaffective disorder: an analysis based on AMDP data.

Authors:  Christopher Baethge; Michaela Jänner; Wolfgang Gaebel; Jaroslav Malevani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-10-17       Impact factor: 5.270

6.  Olfactory Functioning in First-Episode Psychosis.

Authors:  Vidyulata Kamath; Patricia Lasutschinkow; Koko Ishizuka; Akira Sawa
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

7.  Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder.

Authors:  Jonne Lintunen; Heidi Taipale; Antti Tanskanen; Ellenor Mittendorfer-Rutz; Jari Tiihonen; Markku Lähteenvuo
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

8.  Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.

Authors:  Derek K Tracy; Dan W Joyce; S Neil Sarkar; Maria-Jesus Mateos Fernandez; Sukhwinder S Shergill
Journal:  BMC Psychiatry       Date:  2015-07-25       Impact factor: 3.630

9.  Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder.

Authors:  Rashmi Patel; Hitesh Shetty; Richard Jackson; Matthew Broadbent; Robert Stewart; Jane Boydell; Philip McGuire; Matthew Taylor
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

10.  The Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosis.

Authors:  Edith J Liemburg; Stynke Castelein; Frank van Es; Anne Neeltje Scholte-Stalenhoef; Gerard van de Willige; Henderikus Smid; Ellen Visser; Henderikus Knegtering; Richard Bruggeman
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.